Cargando…
Point of use production of liposomal solubilised products
With the progression towards personalised and age-appropriate medicines, the production of drug loaded liposomes at the point of care would be highly desirable. In particular, liposomal solubilisation agents that can be produced rapidly and easily would provide a new option in personalised medicines...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier/North-Holland Biomedical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5821685/ https://www.ncbi.nlm.nih.gov/pubmed/29225099 http://dx.doi.org/10.1016/j.ijpharm.2017.12.012 |
_version_ | 1783301535009079296 |
---|---|
author | Khadke, Swapnil Stone, Peter Rozhin, Aleksey Kroonen, Jerome Perrie, Yvonne |
author_facet | Khadke, Swapnil Stone, Peter Rozhin, Aleksey Kroonen, Jerome Perrie, Yvonne |
author_sort | Khadke, Swapnil |
collection | PubMed |
description | With the progression towards personalised and age-appropriate medicines, the production of drug loaded liposomes at the point of care would be highly desirable. In particular, liposomal solubilisation agents that can be produced rapidly and easily would provide a new option in personalised medicines. Such a process could also be used as a rapid tool for the formulation and pre-clinical screening of low soluble drugs. Within this paper, we outline a novel easy-to-use production method for point of use production of liposome solubilised drugs. Our results demonstrate that pre-formed multilamellar liposomes, stored in a fresh or frozen format, can be bilayer loaded with low solubility drugs using a simple bath sonication process. Sonication is undertaken in a sealed vial allowing the contents to remain sterile. Liposomes around 100 nm were prepared and these liposomes were able to increase the amount of drug dissolved by up to 10 fold. These liposomal solubilisation agents were stable in terms of size and drug solubilisation for up to 8 days when stored in the fridge making them an easy to use and robust small-scale tool for drug solubilisation. |
format | Online Article Text |
id | pubmed-5821685 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Elsevier/North-Holland Biomedical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-58216852018-02-26 Point of use production of liposomal solubilised products Khadke, Swapnil Stone, Peter Rozhin, Aleksey Kroonen, Jerome Perrie, Yvonne Int J Pharm Article With the progression towards personalised and age-appropriate medicines, the production of drug loaded liposomes at the point of care would be highly desirable. In particular, liposomal solubilisation agents that can be produced rapidly and easily would provide a new option in personalised medicines. Such a process could also be used as a rapid tool for the formulation and pre-clinical screening of low soluble drugs. Within this paper, we outline a novel easy-to-use production method for point of use production of liposome solubilised drugs. Our results demonstrate that pre-formed multilamellar liposomes, stored in a fresh or frozen format, can be bilayer loaded with low solubility drugs using a simple bath sonication process. Sonication is undertaken in a sealed vial allowing the contents to remain sterile. Liposomes around 100 nm were prepared and these liposomes were able to increase the amount of drug dissolved by up to 10 fold. These liposomal solubilisation agents were stable in terms of size and drug solubilisation for up to 8 days when stored in the fridge making them an easy to use and robust small-scale tool for drug solubilisation. Elsevier/North-Holland Biomedical Press 2018-02-15 /pmc/articles/PMC5821685/ /pubmed/29225099 http://dx.doi.org/10.1016/j.ijpharm.2017.12.012 Text en © 2017 The Author(s) http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Khadke, Swapnil Stone, Peter Rozhin, Aleksey Kroonen, Jerome Perrie, Yvonne Point of use production of liposomal solubilised products |
title | Point of use production of liposomal solubilised products |
title_full | Point of use production of liposomal solubilised products |
title_fullStr | Point of use production of liposomal solubilised products |
title_full_unstemmed | Point of use production of liposomal solubilised products |
title_short | Point of use production of liposomal solubilised products |
title_sort | point of use production of liposomal solubilised products |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5821685/ https://www.ncbi.nlm.nih.gov/pubmed/29225099 http://dx.doi.org/10.1016/j.ijpharm.2017.12.012 |
work_keys_str_mv | AT khadkeswapnil pointofuseproductionofliposomalsolubilisedproducts AT stonepeter pointofuseproductionofliposomalsolubilisedproducts AT rozhinaleksey pointofuseproductionofliposomalsolubilisedproducts AT kroonenjerome pointofuseproductionofliposomalsolubilisedproducts AT perrieyvonne pointofuseproductionofliposomalsolubilisedproducts |